Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

Top 10 Copper-producing Companies (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

7 Biggest Lithium-mining Companies

Top 10 Countries for Natural Gas Production (Updated 2024)

Top Stories This Week: Silver Price Breaks US$30, "Big Short" Investor Burry Gets into Gold

5 Silver Stocks that Pay Dividends (Updated 2024)

Nick Hodge: Gold to Remain Bullish, Watch Silver, Copper and Uranium Too

Can You Invest in Elon Musk’s Neuralink?

Trending Press Releases

Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero

CISCO REPORTS THIRD QUARTER EARNINGS

Galan Lithium Limited (ASX: GLN) – Trading Halt

Lancaster Resources Receives BLM Drilling Approval for Alkali Flat Lithium Brine Project

DLE Pilot Plant Produces High Quality Eluate

Forward Water Technologies Corp. and Fraser Mackenzie Accelerator Corp. Announce Proposed Business Combination

More Press Releases
Trending Companies

Fungtional Labs

Galan Lithium

GLN:AU

Fortune Minerals

FT:CA

Firebird Metals

FRB:AU
More Companies
Trending Reports

2024 Lithium Market Outlook (Updated for Q2)

Silver Price Forecast - What Happened And Where Do We Go From Here?

2024 Gold Outlook Report

2024 Copper Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold
Copper
Uranium
Oil and Gas
Artificial Intelligence
Biotech
loader

Dyne Therapeutics Inc.

NASDAQ:DYN
Press Releases

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints

Dyne Therapeutics to Host Virtual Investor Event to Review New Clinical Data from the ACHIEVE and DELIVER Trials Tomorrow, May 20 at 8:00 a.m. ET

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

×